.png)
New partner PRESURGY for the launch of our medical device Tensi+ in Spain.
June 5, 2023 – Stimuli Technology today announced an agreement with Presurgy for the distribution of the Tensi+ medical device in Spain.
PRESURGY is a company specialized in innovative medical products, highly qualified and proven, for the specialties of Urology, Gynecology and Surgery.
Their mission is to introduce in the market minimally invasive, high performance products that, on the one hand substantially increase the quality of life of patients and on the other, optimize the medical resources of the healthcare sector throughout Spain.
Our team is so glad to improve the quality of life of more and more patients 𝙖𝙘𝙧𝙤𝙨𝙨 𝙀𝙪𝙧𝙤𝙥𝙚 by giving them access to innovation in OAB treatment with our medical device Tensi+.
Our Tensi+ treatment has been prescribed by more than 500 physicians and adopted by 10,000 patients in France which demonstrates the success of our medical device.
Presurgy is key to accelerate our extension in Spain.
About PRESURGY :
PRESURGY is a company founded in 2003 by professional experts with a long history in the field of Urology and Gynecology. An agile and dynamic company that offers the highest quality and support to surgeons. Innovation, Quality and Service are the values that define their company.
About Stimuli Technology :
Stimuli Technology is a French MedTech company created by the startup studio Technofounders in 2018. They promote research from French laboratories by creating technology startups with high added value, thus meeting a requirement for rapid time to market and a real economic potential. The startups created present a significant societal impact and opportunities for technological disruption. Stimuli Technology developed Tensi+ in collaboration with specialists in urology and rehabilitation medicine, renowned in France and in Europe. This treatment is a revolutionary solution for patients and healthcare professionals to treat overactive bladder. For more information: tensiplus.com
